Fingerprint
Dive into the research topics of 'Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?
Nathan W.D. Lamond, Chris Skedgel, Tallal Younis
Research output: Contribution to journal › Review article › peer-review
14
Citations
(Scopus)